Thousands of individuals with undiagnosed illnesses, including HIV, have been identified through routine blood testing in emergency departments. The National Health Service (NHS) initiative, testing over 4,000 people, uncovered cases of undiagnosed hepatitis B and C, which can progress to liver cirrhosis.
The UK Health Security Association released findings from its bloodborne virus (BBV) testing program conducted at 34 emergency departments in high HIV prevalence areas. This initiative aligns with the government’s target to eliminate new HIV transmissions by 2030. Among those tested, one in every 2,000 individuals tested positive for HIV, with half of them already in advanced stages of the disease.
Public Health Minister Ashley Dalton praised the program, describing it as highly successful in identifying infections that would have otherwise gone unnoticed. By integrating testing into standard emergency care practices, patients can access life-saving treatments sooner, benefiting both the individuals and the broader community.
HIV is a virus that compromises the body’s immune system, potentially progressing to AIDS without treatment. While there is no definitive cure, proper medical management can effectively control the virus once contracted. Hepatitis, which impacts the liver and can lead to cirrhosis and liver cancer, was also detected in the screenings, with rates of hepatitis B and C diagnoses reported.
Under the BBV program, A&E patients undergo automatic testing for HIV, hepatitis B, and hepatitis C unless they choose to opt out. Remarkably, around 70% of eligible individuals consented to testing. In the initial 33 months of the initiative, numerous infections were identified, leading to the provision of life-saving treatments to affected patients.
Dr. Claire Fuller, NHS England’s medical director, emphasized the program’s significance in early detection, enabling more individuals to access life-saving treatments, which not only avert long-term health complications but also reduce the risk of transmitting the viruses to others.
Dr. Sema Mandal, Consultant Epidemiologist and deputy director at the UKHSA, highlighted the impact of the NHS opt-out testing program in emergency departments, emphasizing the critical role it plays in reaching individuals unaware of their HIV, hepatitis B, or hepatitis C status. The need for enhanced awareness, expanded testing, and improved support for affected individuals was underscored, emphasizing the life-saving potential of early diagnosis.